OR Anesthesia Services and Admixtures
In an operating room, every
decision is critical. Accuracy is never more important than when making
a split-second choice that can make or break the quality of patient
care. That's why PharMEDium
anesthesia services, beta blocker compounding and antibiotic
compounding improve drug name recognition in critical situations. We
use labels with American Society of Anesthesiologists-endorsed ASTM
color differentiation by drug class to help make sure you always have the
information you need.We know accuracy begins long before a compounded preparation enters the OR. That’s why we’ve developed an anesthesia services process of 200% inspection, along with a highly specialized system that utilizes automated bar code verification to ensure the Right drug in the Right concentration is present in each syringe and is labeled correctly, every time. Our tamper-evident packaging enhances patient care by reducing the potential for diversion and waste.
Here are a few of the anesthesia services PharMEDium offers:
| Antibiotics cefazolin Anticholinergics glycopyrrolate atropine Beta Blockers labetalol esmolol Blockade Agents succinylcholine rocuronium vecuronium | Induction Agents ketamine Local Anesthetics bupivacaine ropivacaine lidocaine Narcotics fentanyl morphine PF hydromorphone |
Reversal Agents neostigmine Sedatives midazolam Vasopressors phenylephrine ephedrine  |
PharMEDium anesthesia services
Enhance patient safety
- American Society of Anesthesiologist-endorsed ASTM color differentiated labels by drug class
- Two out of three anesthesiologists prefer the unique label design offered only on PharMEDium compounded anesthesia syringe preparations. Results show improved drug name recognition when viewing a syringe preparation under simulated operating room conditions1
- Labeling that utilizes a dual-drug name band, vertical drug name stripe, reverse print, TALL man lettering to differentiate each drug resulting in the drug name appearing four times on the label
- Tamper-evident packaging
- Eliminate the use of multidose drug vials to reduce the potential for a nosocomial infection2
- Compliance with the Joint Commission Patient Safety Goal NPSG.03.04.01 for labeling of all medications used in the perioperative environment
Improve resource utilization
- Reduce or eliminate labor costs associated with preparing unit dose syringe preparations
- Improve efficiency in the OR
- Reduce drug vial waste
- Improve patient traceability
- Streamline controlled substance reconciliation
- Extended stability in conjunction with tamper evidence may reduce or eliminate waste
2 Germain JM, Et al. Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during anesthesia. Infection Control Hospital Epidemiology 2005; 26(9):789-92.
